Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 55,356 shares at $25.37 ($1.4M) on 2021-05-18, disclosed to the SEC on 2021-05-18.
Open-market sale of $1.4M ORIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.36 | 13,896 | $352K | 25.1% |
| 2 | $25.36 | 13,896 | $352K | 25.1% |
| 3 | $25.05 | 2,550 | $64K | 4.6% |
| 4 | $25.05 | 2,550 | $64K | 4.6% |
| 5 | $25.37 | 11,132 | $282K | 20.1% |
| 6 | $25.37 | 11,132 |
| $282K |
| 20.1% |
| 7 | $26.03 | 200 | $5K | 0.4% |
| Total | $25.34 avg | 55,356 | $1.4M | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |